Source: International Congress 2015 – Systemic and airway biomarkers
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hollie Bancroft (Birmingham , United Kingdom), Hollie Bancroft, Roy Stewart, Babu Naidu, Simon Trotter. The use of immunohistochemical stains to identify Langerhans cells in pulmonary histiocytosis. Eur Respir J 2015; 46: Suppl. 59, 3886

Member's Comments

No comment yet.

Related content which might interest you: Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH) Source: International Congress 2015 – IIPs: orphan Year: 2015 Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Adult pulmonary Langerhans' cell histiocytosis Source: Eur Respir J 2006; 27: 1272-1285 Year: 2006 Change of A549 cells characteristics upon stimulation with BALF of patients with interstitial lung diseases Source: International Congress 2014 – ILDs 4 Year: 2014 Ex vivo trans-differentiation of primary human alveolar epithelial cells type II by TGFb Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Pulmonary alveolar proteinosis: iPS derived macrophages as in-vitro disease model and potential source for novel gene and cell therapies Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases Year: 2013 Modulation of lung CD11c+ dendritic cells by TGF-β in pulmonary fibrosis in mice Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Alveolar type II cells transplantation in pulmonary fibrosis: Effect on the lung macrophage activation Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF alveolar macrophages Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Lung function progression in Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Tryptase+ mast cells associate with fibrotic regions in the lungs of idiopathic pulmonary fibrosis patients; a multiplex staining approach Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease Year: 2016 Angiogenic T cells in interstitial lung diseases Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 Lung transplantation for pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2005; 26: Suppl. 49, 635s Year: 2005 Pirfenidone suppresses proinflammatory and antiangiogenetic cytokine production by alveolar macrophages (AMs) in idiopathic non specific interstitial pneumonia (iNSIP) Source: International Congress 2014 – ILDs 2 Year: 2014 Distinct gene expression profiles of cultured stromal cells from the patients with idiopathic pulmonary fibrosis and lung adenocarcinoma Source: International Congress 2015 – Translational studies in airway cell biology Year: 2015 Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling? Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Bronchoalveolar lavage cytokine profile in patients with Pulmonary Langerhans Cell Histiocytosis differs from other interstitial lung diseases Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 Expression phenotypes of CD4+ and CD8+ T lymphocytes in bronchoalveolar lavage fluid and blood in lung fibrosis Source: International Congress 2014 – ILDs 2 Year: 2014 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018